PHARMACOR ROXITHROMYCIN roxithromycin 150 mg film coated tablets blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

roxithromycin, Quantity: 150 mg

Disponibbli minn:

Arrotex Pharmaceuticals Pty Ltd

INN (Isem Internazzjonali):

Roxithromycin

Għamla farmaċewtika:

Tablet, film coated

Kompożizzjoni:

Excipient Ingredients: sodium starch glycollate type A; glucose; sodium starch glycollate type B; maize starch; hypromellose; colloidal anhydrous silica; titanium dioxide; purified talc; povidone; propylene glycol; hyprolose; poloxamer; magnesium stearate

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

10 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Adults: Roxithromycin is indicated for the treatment of the following types of mild to moderately severe infections caused by or likely to be caused by susceptible microorganisms: Upper respiratory tract infection: acute pharyngitis, tonsillitis and sinusitis. Lower respiratory tract infection: acute bronchitis and acute exacerbations of chronic bronchitis; community acquired pneumonia. Skin and skin structure infections. Nongonococcal urethritis. Children: ROXITHROMYCIN 150 mg tablets are indicated for the treatment of the following mild to moderately severe infections in children caused by or likely to be caused by susceptible microorganisms: Acute pharyngitis. Acute tonsillitis, impetigo. Appropriate culture and sensitivity tests should be performed when necessary to determine organism susceptibility and thus treatment suitability. Therapy with roxithromycin may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.

Sommarju tal-prodott:

Visual Identification: White to off-white, round, convex film coated tablets.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2008-04-10